← Leaderboards
Steven D Shapiro
Washington University
$21,129,259
Attributed
$22,608,075
Total exposure
15
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–15$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$22,608,075 · 15
By mechanism
R01$12,264,963 · 6
P01$4,582,818 · 2
T32$3,796,872 · 2
P50$1,918,422 · 2
R13$45,000 · 2
M01$0 · 1
Top collaborators
- Naftali Kaminski5 shared
Most similar at Washington University
Same institution · by research overlap
- David H Perlmutter$25,711,247
- David A Rudnick$3,126,164
- Jeffrey H Teckman$1,054,676
- L David Sibley$48,261,605
- Mark E. Lowe$21,007,137
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationChronic Obstructive Airway DiseasePulmonary EmphysemaSmokingLaboratory MouseLungAnimal ModelBaseElastasesNeutrophilResearch PersonnelElastinResponsePathway InteractionsCigarette SmokeCohortClinical ResearchPhenotypeGenesFutureFibrosisHuman SubjectAffectTissues
Grant awards (57)
Targeting Neutrophil Elastase in Lung Cancer$342,593
P50 · FY2015 · CA · contact PI
The Emphysematous Microenvironment Promotes Lung Tumorigenesis and Progression$670,107
R01 · FY2014 · HL · contact PI
Targeting Neutrophil Elastase in Lung Cancer$342,836
P50 · FY2014 · CA · contact PI
Targeting Neutrophil Elastase in Lung Cancer$305,503
P50 · FY2013 · CA · contact PI
Targeting Neutrophil Elastase in Lung Cancer$272,617
P50 · FY2012 · CA · contact PI
Molecular Phenotypes within and across disease boundaries in IPF and COPD$711,424
R01 · FY2011 · HL
Genetics of Asthma and COPD$661,018
P01 · FY2011 · HL · contact PI
Molecular Physiology of the Lung$316,767
T32 · FY2011 · HL · contact PI
Genetics of Asthma and COPD$840,750
P01 · FY2010 · HL · contact PI
Molecular Phenotypes within and across disease boundaries in IPF and COPD$718,962
R01 · FY2010 · HL
Molecular Physiology of the Lung$399,361
T32 · FY2010 · HL · contact PI
Genetics of Asthma and COPD$876,688
P01 · FY2009 · HL · contact PI
Molecular Phenotypes within and across disease boundaries in IPF and COPD$738,001
R01 · FY2009 · HL
Molecular Physiology of the Lung$545,007
T32 · FY2009 · HL · contact PI
Genetic and Environmental Factors Affecting COPD Exacerbations$408,192
R01 · FY2009 · HL · contact PI
Electrophil elastase in lung cancer and COPD$360,484
R01 · FY2009 · HL · contact PI
Molecular Phenotypes within and across disease boundaries in IPF and COPD$18,265
R01 · FY2009 · HL
Genetics of Asthma and COPD$962,212
P01 · FY2008 · HL · contact PI
Molecular Phenotypes within and across disease boundaries in IPF and COPD$770,981
R01 · FY2008 · HL
Genetic and Environmental Factors Affecting COPD Exacerbations$713,287
R01 · FY2008 · HL · contact PI
Molecular Physiology of the Lung$540,691
T32 · FY2008 · HL · contact PI
Electrophil elastase in lung cancer and COPD$360,484
R01 · FY2008 · HL · contact PI
Genetics of Asthma and COPD$847,953
P01 · FY2007 · HL · contact PI
Genetic and Environmental Factors Affecting COPD Exacerbations$728,048
R01 · FY2007 · HL · contact PI
Electrophil elastase in lung cancer and COPD$360,484
R01 · FY2007 · HL · contact PI
Genetic and Environmental Factors Affecting COPD Exacer*$407,016
R01 · FY2006 · HL · contact PI
Electrophil elastase in lung cancer and COPD$371,250
R01 · FY2006 · HL · contact PI
Genetic and Environmental Factors Affecting COPD Exacer*$232,423
R01 · FY2006 · HL · contact PI
Integrated Training in Respiratory Research$542,311
T32 · FY2005 · HL
Genetic and Environmental Factors--COPD Exacerbations$441,284
R01 · FY2005 · HL
Macrophage Elastase in Host Defense$367,350
R01 · FY2005 · HL
CORE--TRANSGENIC/GENE DISRUPTION MOUSE$271,250
P50 · FY2005 · HL
Integrated Training in Respiratory Research$457,515
T32 · FY2004 · HL
Role of Alpha-1-Antitrypsin in COPD$381,400
R01 · FY2004 · HL
Macrophage Elastase in Host Defense$367,350
R01 · FY2004 · HL
INTEGRATED TRAINING IN RESPIRATORY RESEARCH$468,921
T32 · FY2003 · HL
Role of Alpha-1-Antitrypsin in COPD$381,400
R01 · FY2003 · HL
Macrophage Elastase in Host Defense$367,350
R01 · FY2003 · HL
The 2003 Gordon Conference on Elastin and Elastic Tissue$15,000
R13 · FY2003 · HL
INTEGRATED TRAINING IN RESPIRATORY RESEARCH$526,299
T32 · FY2002 · HL
Role of Alpha-1-Antitrypsin in COPD$380,950
R01 · FY2002 · HL
Macrophage Elastase in Host Defense$366,375
R01 · FY2002 · HL
EXTRACELLULAR MATRIX REPAIR IN PULMONARY EMPHYSEMA$344,000
R01 · FY2002 · HL
CORE--TRANSGENIC/GENE DISRUPTION MOUSE$172,411
P50 · FY2002 · HL
Macrophage Elastase in Host Defense$74,999
R01 · FY2002 · HL
Conference--Models of Emphysema: Speeding Progress$30,000
R13 · FY2002 · HL
Palivizumab synagis prophylaxis of respiratory syncytial virus in cystic fibrosis$0
M01 · FY2002 · RR
Role of Alpha-1-Antitrypsin in COPD$371,500
R01 · FY2001 · HL
MACROPHAGE ELASTASE IN EMPHYSEMA$186,685
P01 · FY2001 · HL
EXTRACELLULAR MATRIX REPAIR IN PULMONARY EMPHYSEMA$176,480
R01 · FY2001 · HL
EXTRACELLULAR MATRIX REPAIR IN PULMONARY EMPHYSEMA$135,520
R01 · FY2001 · HL
Palivizumab synagis prophylaxis of respiratory syncytial virus in cystic fibrosis$0
M01 · FY2001 · RR
EXTRACELLULAR MATRIX REPAIR IN PULMONARY EMPHYSEMA$312,000
R01 · FY2000 · HL
NEUTROPHIL ELASTASE AND SMOKING-RELATED EMPHYSEMA$227,597
R01 · FY2000 · HL
CORE--TRANSGENIC/GENE DISRUPTION MOUSE$211,212
P50 · FY2000 · HL
MACROPHAGE ELASTASE IN EMPHYSEMA$207,512
P01 · FY2000 · HL
Palivizumab synagis prophylaxis of respiratory syncytial virus in cystic fibrosis$0
M01 · FY2000 · RR